CaV1.3 (CACNA1D) showed higher expression in samples from patients with activated B-cell-like DLBCL (ABC-DLBCL), whereas expression of CaV1.1 (CACNA1S), CaV1.2 (CACNA1C), and CaV1.4 (CACNA1F) were higher in germinal centre B-cell like DLBCL (GCB-DLBCL) (156). Here, CACNA1S is linked to diffuse large B-cell lymphoma.